Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 51683 |
| Drug Identification Number | 02439387 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 5 mg/mL |
| Dosage form(s) | Solution |
| Route of administration | Block/Infiltration, Epidural |
| Packaging size | 10 mL Ampoule |
| ATC code | N01BB |
| ATC description | Anesthecics, local |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-06-01 |
| Estimated end date | 2019-06-30 |
| Actual end date | 2019-09-12 |
| Shortage status | Resolved |
| Updated date | 2019-09-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-06-06 | English | Compare |
| v2 | 2018-06-06 | French | Compare |
| v3 | 2018-08-30 | English | Compare |
| v4 | 2018-08-30 | French | Compare |
| v5 | 2019-03-01 | English | Compare |
| v6 | 2019-03-01 | French | Compare |
| v7 | 2019-09-13 | English | Compare |
| v8 | 2019-09-13 | French | Compare |
Showing 1 to 8 of 8